Results 71 to 80 of about 497 (127)

Implementing healthcare professionals' training during COVID-19: a pre and post-test design for simulation training. [PDF]

open access: yesSao Paulo Med J, 2021
Santos TM   +10 more
europepmc   +1 more source

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy. [PDF]

open access: yesBMC Infect Dis, 2022
Crabtree-Ramirez B   +14 more
europepmc   +1 more source

Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023. [PDF]

open access: yesEuro Surveill, 2023
Gouveia C   +10 more
europepmc   +1 more source

Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025. [PDF]

open access: yesEuro Surveill
Guiomar R   +8 more
europepmc   +1 more source

Temperature: a driving factor for Meloidogyne floridensis migration toward different hosts. [PDF]

open access: yesJ Nematol, 2021
Leitão DAHS   +4 more
europepmc   +1 more source

Correction to: Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

open access: yesPneumonia (Nathan)
Gomes-Silva J   +7 more
europepmc   +1 more source

Editorial: Global excellence in translational immunology: Europe. [PDF]

open access: yesFront Immunol, 2023
Casiraghi F, Perico N, Remuzzi G.
europepmc   +1 more source

Two <i>Streptococcus agalactiae</i> ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe. [PDF]

open access: yesFront Microbiol
Martins ER   +5 more
europepmc   +1 more source

A Restrictive Versus a Liberal Transfusion Strategy in Patients With Spontaneous Intracerebral Hemorrhage: A Secondary Analysis of TRAIN Randomized Clinical Trial. [PDF]

open access: yesStroke
Faso C   +27 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy